Consistent Patterns in the Development and Immunodominance of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD8+ T-Cell Responses following Acute HIV-1 Infection
暂无分享,去创建一个
Philip J. R. Goulder | Eric S. Rosenberg | E. Rosenberg | M. Altfeld | B. Walker | Xu G. Yu | M. Addo | P. Goulder | M. Johnston | William R. Rodriguez | Bruce D. Walker | Marcus Altfeld | Marylyn M. Addo | Paul K. Lee | Cecily A. Fitzpatrick | Mary N. Johnston | Daryld Strick | C. A. Fitzpatrick | D. Strick | Xu G. Yu | Xu G. Yu | Xu G. Yu
[1] B. Walker,et al. HLA-B57-Restricted Cytotoxic T-Lymphocyte Activity in a Single Infected Subject toward Two Optimal Epitopes, One of Which Is Entirely Contained within the Other , 2000, Journal of Virology.
[2] B. Walker,et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals , 1987, Nature.
[3] M. Altfeld,et al. The role of CD4(+) T helper cells in the cytotoxic T lymphocyte response to HIV-1. , 2000, Current opinion in immunology.
[4] Stephen P. Schoenberger,et al. Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation , 2001, Nature Immunology.
[5] E. Rosenberg,et al. Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection , 2001, The Journal of experimental medicine.
[6] G. M. Ortiz,et al. The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection , 2001, AIDS.
[7] P. Earl,et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. , 2002, Vaccine.
[8] B. Walker,et al. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. , 1998, Journal of immunology.
[9] B. Walker,et al. Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition , 1997, Journal of virology.
[10] Susan M. Kaech,et al. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells , 2001, Nature Immunology.
[11] D. Montefiori,et al. Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[12] Eric G. Pamer,et al. Early Programming of T Cell Populations Responding to Bacterial Infection1 , 2000, The Journal of Immunology.
[13] E. Rosenberg,et al. Identification of Dominant Optimal HLA-B60- and HLA-B61-Restricted Cytotoxic T-Lymphocyte (CTL) Epitopes: Rapid Characterization of CTL Responses by Enzyme-Linked Immunospot Assay , 2000, Journal of Virology.
[14] E. Rosenberg,et al. Vpr Is Preferentially Targeted by CTL During HIV-1 Infection1 , 2001, The Journal of Immunology.
[15] R. Young,et al. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[16] W. Blattner,et al. Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1. , 1997, The Journal of clinical investigation.
[17] Steven M. Wolinsky,et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes , 2002, Nature.
[18] E. Rosenberg,et al. Immune control of HIV-1 after early treatment of acute infection , 2000, Nature.
[19] R. Kaul,et al. New Insights into Host Factors in HIV-1 Pathogenesis , 2001, Cell.
[20] J. Kilby,et al. Perspectives on inducing efficient immune control of HIV-1 replication - a new goal for HIV therapeutics? , 2001, AIDS (London).
[21] J. Sidney,et al. HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. , 1998, Current opinion in immunology.
[22] S. Rowland-Jones,et al. Cellular immune responses to HIV , 2001, Nature.
[23] G. Shaw,et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.
[24] E. Rosenberg,et al. Substantial Differences in Specificity of HIV-Specific Cytotoxic T Cells in Acute and Chronic HIV Infection , 2001, The Journal of experimental medicine.
[25] Xiping Wei,et al. Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.
[26] L. Weinberger,et al. Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques , 1999, The Journal of experimental medicine.
[27] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[28] V. Appay,et al. Memory CD8+ T cells in HIV infection. , 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[29] Martin A. Nowak,et al. Antigenic oscillations and shifting immunodominance in HIV-1 infections , 1995, Nature.
[30] M. Altfeld,et al. Less is more? STI in acute and chronic HIV-1 infection , 2001, Nature Medicine.
[31] Alessandro Sette,et al. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia , 2000, Nature.
[32] B. Walker,et al. Anti-HIV cellular immunity: recent advances towards vaccine design. , 1999, AIDS.
[33] Bucy Rp,et al. Perspectives on inducing efficient immune control of HIV-1 replication--a new goal for HIV therapeutics? , 2001 .
[34] C. Pitcher,et al. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression , 1999, Nature Medicine.
[35] Hans-Georg Rammensee,et al. MHC ligands and peptide motifs: first listing , 2004, Immunogenetics.
[36] Todd M. Allen,et al. CD8+ Lymphocytes from Simian Immunodeficiency Virus-Infected Rhesus Macaques Recognize 14 Different Epitopes Bound by the Major Histocompatibility Complex Class I Molecule Mamu-A*01: Implications for Vaccine Design and Testing , 2001, Journal of Virology.
[37] A. Hughes,et al. Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys. , 1991, Journal of immunology.
[38] Henryk Mach,et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity , 2002, Nature.
[39] A. Oxenius,et al. Cytotoxic T Lymphocyte Responses to Human Immunodeficiency Virus: Control and Escape , 2000, Stem cells.
[40] R. Paredes,et al. HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection , 2001, AIDS.
[41] E. Rosenberg,et al. Functionally Inert HIV-Specific Cytotoxic T Lymphocytes Do Not Play a Major Role in Chronically Infected Adults and Children , 2000, The Journal of experimental medicine.
[42] B. Walker,et al. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine development. , 1997, Journal of immunology.
[43] A. Simon,et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. , 2000, Science.
[44] E. Rosenberg,et al. Rapid Definition of Five Novel HLA-A∗3002-Restricted Human Immunodeficiency Virus-Specific Cytotoxic T-Lymphocyte Epitopes by Elispot and Intracellular Cytokine Staining Assays , 2001, Journal of Virology.
[45] D. Montefiori,et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.
[46] A. Trkola,et al. HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy. , 1999, The Journal of clinical investigation.
[47] M. Bunce,et al. Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequence-specific primers (PCR-SSP). , 1995, Tissue antigens.
[48] R. Siliciano,et al. Autologous strain-specific cytolytic T lymphocyte responses directed against human immunodeficiency virus type 1 Env. , 1998, AIDS research and human retroviruses.